InsiderClue
← All stocks

Emergent BioSolutions Inc.

EBS Net selling
CIK 0001367644 #3771 in the set updated 20 Sep 2026
Bought (120 mo)
$462.18K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$125.91M
$719.00K on a plan · $59.18M straight out of an exercise
Sold at will
$66.02M
108 of 200 sales
Net
−$125.45M
−$65.56M against sales at will

By person

30 insiders · 207 transactions
3.9×

Joseph Papa holds only 3.9 times base salary in stock. $4.14M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Papa last reported holding, valued at $8.40, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
El-Hibri Fuad
Director
—
$62.78M (58)
−$62.78M
10,183,813
19.86%
$85.54M
+37.8%
Abdun-Nabi Daniel
CEO
—
$14.41M (13) scheduled
−$14.41M
144,553
0.2819%
$1.21M
−20.3%
Havey Adam
EVP, Business Operations
—
$10.53M (23) scheduled
−$10.53M
174,398
0.3401%
$1.46M
+323.3%
Kramer Robert
President and CEO
—
$10.12M (5) scheduled
−$10.12M
507,059
0.9889%
$4.26M
+619.3%
Richard Ronald
Director
—
$7.68M (19) scheduled
−$7.68M
123,761
0.2414%
$1.04M
+487.9%
Bailey Sue
Director
—
$4.45M (15)
−$4.45M
24,427
0.0476%
$205.19K
−31.8%
SULLIVAN LOUIS W
Director
—
$4.09M (4) scheduled
−$4.09M
139,098
0.2713%
$1.17M
+288.3%
Harsanyi Zsolt
Chairman
—
$2.74M (6)
−$2.74M
149,076
0.2907%
$1.25M
+316.2%
Zoon Kathryn C
Director
—
$2.19M (26)
−$2.19M
79,941
0.1559%
$671.50K
—
Hauer Jerome M
Director
—
$2.13M (7)
−$2.13M
57,508
0.1122%
$483.07K
+209.4%
JOULWAN GEORGE A
Director
—
$2.04M (6)
−$2.04M
40,244
0.0785%
$338.05K
+82.0%
Kirk Sean
EVP, Manufacturing & Tech Ops
—
$965.64K (3) scheduled
−$965.64K
17,776
0.0347%
$149.32K
+45.9%
DeGolyer Donald W
Director
—
$658.20K (5)
−$658.20K
129,721
0.2530%
$1.09M
—
PAPA JOSEPH C
President and CEO
$349.80K (1)
—
+$349.80K
493,153
0.9618%
$4.14M
—
Glessner Coleen
EVP, Quality & Ethics, and CPL
—
$306.08K (1)
−$306.08K
202,201
0.3944%
$1.70M
—
Fowler Neal Franklin
Director
—
$204.05K (1)
−$204.05K
160,847
0.3137%
$1.35M
—
Dayal Sujata Tyagi
Director
—
$201.13K (3) scheduled
−$201.13K
100,563
0.1961%
$844.73K
—
Katkin Keith
Director
—
$177.60K (2) scheduled
−$177.60K
96,294
0.1878%
$808.87K
—
White Marvin L
Director
—
$171.02K (1)
−$171.02K
113,839
0.2220%
$956.25K
—
LINDAHL RICHARD S
EVP, Chief Financial Officer
$112.38K (1)
—
+$112.38K
374,083
0.7296%
$3.14M
—
Williams Paul Anthony
SVP, Products Business
—
$58.96K (2) scheduled
−$58.96K
159,098
0.3103%
$1.34M
+1,597%
Mulligan Seamus
Director
—
—
—
601,731
1.17%
$5.05M
+1.3%
Fox Jennifer Lynne
EVP, Ext Aff, GC, Corp Sec
—
—
—
186,382
0.3635%
$1.57M
+2,471%
Hartzel William
SVP, Bioservices
—
—
—
185,558
0.3619%
$1.56M
+416.6%
Lowry Simon C
SVP, R&D, CMO
—
—
—
177,914
0.3470%
$1.49M
—
Perl Jessica
SVP, General Counsel, Corp Sec
—
—
—
165,286
0.3224%
$1.39M
+2,329%
SARAN ATUL
EVP, Chief Strat & Dev Officer
—
—
—
86,645
0.1690%
$727.82K
—
Strei Katherine
EVP, Chief HR Officer
—
—
—
62,824
0.1225%
$527.72K
+532.0%
FOWLER JOHN D JR
Director
—
—
—
30,350
0.0592%
$254.94K
—
Smith Karen L.
EVP, Chief Medical Officer
—
—
—
11,888
0.0232%
$99.86K
+88.4%

Individual transactions

79
Insider
Date
Role
Action
Shares
Price
Amount
Richard Ronald
5 Dec 2025
Director
Sold after exercise
14,884
$11.90
$177.09K
Richard Ronald
5 Dec 2025
Director
Sold after exercise
7,100
$12.11
$85.99K
Havey Adam
1 Mar 2021
EVP, Business Operations
Sold after exercise
20,145
$99.02
$1.99M
Havey Adam
1 Mar 2021
EVP, Business Operations
Sold after exercise
17,134
$99.62
$1.71M
Kramer Robert
8 Feb 2021
President and CEO
Sold after exercise
13,000
$120.03
$1.56M
Kramer Robert
8 Feb 2021
President and CEO
Sold after exercise
32,397
$120.03
$3.89M
Kramer Robert
21 Jan 2021
President and CEO
Sold after exercise
21,900
$110.03
$2.41M
Kramer Robert
20 Jan 2021
President and CEO
Sold after exercise
2,232
$110.00
$245.52K
Kramer Robert
15 Jan 2021
President and CEO
Sold after exercise
19,026
$106.01
$2.02M
El-Hibri Fuad
10 Nov 2020
Chairman
Sold after exercise
19,391
$88.21
$1.71M
El-Hibri Fuad
9 Nov 2020
Chairman
Sold after exercise
20,000
$95.26
$1.91M
El-Hibri Fuad
3 Nov 2020
Chairman
Sold after exercise
20,000
$90.74
$1.81M
El-Hibri Fuad
2 Nov 2020
Chairman
Sold after exercise
20,000
$90.44
$1.81M
SULLIVAN LOUIS W
2 Sep 2020
Director
Sold after exercise
7,893
$111.23
$877.90K
SULLIVAN LOUIS W
2 Sep 2020
Director
Sold after exercise
20,525
$111.22
$2.28M
Richard Ronald
27 Apr 2020
Director
Sold after exercise
7,893
$78.00
$615.65K
Havey Adam
20 Apr 2020
EVP, Business Operations
Sold after exercise
17,009
$69.00
$1.17M
Havey Adam
17 Apr 2020
EVP, Business Operations
Sold after exercise
20,414
$65.00
$1.33M
Kirk Sean
6 Apr 2020
EVP, Manufacturing & Tech Ops
Sold after exercise
7,293
$60.00
$437.58K
Kirk Sean
6 Apr 2020
EVP, Manufacturing & Tech Ops
Sold after exercise
3,135
$60.00
$188.10K
Kirk Sean
6 Apr 2020
EVP, Manufacturing & Tech Ops
Sold after exercise
5,666
$60.00
$339.96K
SULLIVAN LOUIS W
4 Mar 2020
Director
Sold after exercise
7,893
$58.96
$465.36K
SULLIVAN LOUIS W
4 Mar 2020
Director
Sold after exercise
7,893
$58.96
$465.36K
El-Hibri Fuad
27 Feb 2020
Chairman
Sold after exercise
9,837
$56.97
$560.41K
El-Hibri Fuad
26 Feb 2020
Chairman
Sold after exercise
13,619
$58.70
$799.44K
El-Hibri Fuad
21 Feb 2020
Chairman
Sold after exercise
18,567
$64.90
$1.20M
Richard Ronald
21 Feb 2020
Director
Sold after exercise
5,152
$65.00
$334.88K
El-Hibri Fuad
20 Feb 2020
Chairman
Sold after exercise
4,751
$64.90
$308.34K
El-Hibri Fuad
18 Feb 2020
Chairman
Sold after exercise
15,614
$63.90
$997.73K
El-Hibri Fuad
14 Feb 2020
Chairman
Sold after exercise
4,386
$63.90
$280.27K
El-Hibri Fuad
12 Feb 2020
Chairman
Sold after exercise
13,720
$62.90
$862.99K
El-Hibri Fuad
11 Feb 2020
Chairman
Sold after exercise
6,280
$62.90
$395.01K
Richard Ronald
7 Nov 2019
Director
Sold after exercise
5,153
$60.00
$309.18K
El-Hibri Fuad
28 Feb 2019
Chairman
Sold after exercise
6,987
$58.47
$408.53K
El-Hibri Fuad
27 Feb 2019
Chairman
Sold after exercise
10,369
$58.24
$603.89K
El-Hibri Fuad
26 Feb 2019
Chairman
Sold after exercise
10,369
$59.65
$618.51K
Bailey Sue
27 Nov 2018
Director
Sold after exercise
3,158
$69.62
$219.86K
Bailey Sue
27 Nov 2018
Director
Sold after exercise
4,736
$69.62
$329.72K
Bailey Sue
27 Nov 2018
Director
Sold after exercise
1,579
$69.62
$109.93K
Bailey Sue
27 Nov 2018
Director
Sold after exercise
8,244
$69.62
$573.94K
Richard Ronald
7 Nov 2018
Director
Sold after exercise
7,893
$70.00
$552.51K
Havey Adam
2 Nov 2018
EVP, Business Operations
Sold after exercise
6,168
$64.50
$397.84K
Havey Adam
1 Nov 2018
EVP, Business Operations
Sold after exercise
2,011
$63.50
$127.70K
Havey Adam
17 Oct 2018
EVP, Business Operations
Sold after exercise
314
$61.50
$19.31K
Havey Adam
16 Oct 2018
EVP, Business Operations
Sold after exercise
3,840
$63.50
$243.84K
Havey Adam
16 Oct 2018
EVP, Business Operations
Sold after exercise
6,165
$61.50
$379.15K
Havey Adam
15 Oct 2018
EVP, Business Operations
Sold after exercise
661
$60.67
$40.10K
Havey Adam
15 Oct 2018
EVP, Business Operations
Sold after exercise
6,165
$60.03
$370.08K
Havey Adam
15 Oct 2018
EVP, Business Operations
Sold after exercise
6,165
$60.15
$370.85K
Abdun-Nabi Daniel
17 Sep 2018
CEO
Sold after exercise
1,319
$65.00
$85.74K
Abdun-Nabi Daniel
14 Sep 2018
CEO
Sold after exercise
28,220
$65.00
$1.83M
Abdun-Nabi Daniel
4 Sep 2018
CEO
Sold after exercise
60,000
$60.54
$3.63M
Richard Ronald
21 Aug 2018
Director
Sold after exercise
7,793
$60.02
$467.71K
Richard Ronald
3 Aug 2018
Director
Sold after exercise
100
$60.00
$6.00K
Richard Ronald
17 Apr 2018
Director
Sold after exercise
7,893
$55.00
$434.12K
Hauer Jerome M
22 Jan 2018
Director
Sold after exercise
5,152
$50.91
$262.29K
Abdun-Nabi Daniel
2 Jan 2018
President & CEO
Sold after exercise
21,906
$47.91
$1.05M
Abdun-Nabi Daniel
13 Dec 2017
President & CEO
Sold after exercise
20,000
$45.99
$919.80K
Richard Ronald
12 Dec 2017
Director
Sold after exercise
23,681
$45.02
$1.07M
El-Hibri Fuad
29 Nov 2017
Chairman
Sold after exercise
27,983
$42.08
$1.18M
El-Hibri Fuad
28 Nov 2017
Chairman
Sold after exercise
20,000
$41.59
$831.80K
JOULWAN GEORGE A
7 Nov 2017
Director
Sold after exercise
10,305
$41.24
$424.98K
JOULWAN GEORGE A
7 Nov 2017
Director
Sold after exercise
3,946
$41.24
$162.73K
Abdun-Nabi Daniel
3 Nov 2017
President & CEO
Sold after exercise
20,000
$42.92
$858.40K
Abdun-Nabi Daniel
3 Nov 2017
President & CEO
Sold after exercise
11,508
$42.50
$489.09K
Richard Ronald
28 Sep 2017
Director
Sold after exercise
22,415
$40.00
$896.60K
Abdun-Nabi Daniel
27 Sep 2017
President & CEO
Sold after exercise
15,000
$39.92
$598.77K
Havey Adam
27 Sep 2017
EVP, Business Operations
Sold after exercise
7,885
$39.50
$311.46K
Richard Ronald
27 Sep 2017
Director
Sold after exercise
1,266
$40.00
$50.64K
Havey Adam
8 Sep 2017
EVP, Business Operations
Sold after exercise
7,885
$37.06
$292.24K
Abdun-Nabi Daniel
31 Aug 2017
President & CEO
Sold after exercise
15,000
$37.21
$558.15K
Hauer Jerome M
15 Aug 2017
Director
Sold after exercise
10,776
$35.83
$386.15K
Bailey Sue
17 Jan 2017
Director
Sold after exercise
2,061
$29.78
$61.37K
Bailey Sue
17 Jan 2017
Director
Sold after exercise
3,157
$29.78
$94.01K
Bailey Sue
17 Jan 2017
Director
Sold after exercise
4,735
$29.78
$141.00K
Bailey Sue
17 Jan 2017
Director
Sold after exercise
3,157
$29.78
$94.01K
Bailey Sue
17 Jan 2017
Director
Sold after exercise
3,157
$29.78
$94.01K
Bailey Sue
17 Jan 2017
Director
Sold after exercise
3,157
$29.78
$94.01K
Abdun-Nabi Daniel
10 Jan 2017
President and CEO
Sold after exercise
28,240
$31.28
$883.30K
Show all 207 transactions →

What was left out

Form 4 filings counted 418
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 79
Sales at will 108
Transactions with no price 0
Shares from compensation/vesting 9,734,290
Sales filed before the plan box existed 97
History held since 10 Nov 2016